Ruth M. Rothstein CORE Center

CHOP's Hemostasis and Thrombosis Center Celebrates 50th Anniversary

Retrieved on: 
Wednesday, June 7, 2023
Ruth M. Rothstein CORE Center, Bleeding, Vein, CHOP, HIV, Hematology, Mother, Disability, Emicizumab, Hockey, Therapy, Novel, Not, Haemophilia, IX, Philadelphia, Coagulopathy, DSM-IV codes, Bleeding diathesis, Child, HTC, CDC, Pain, Social, Disorder, AIDS, MD, Patient, Nursing, Division, Maternal and Child Health Bureau, Thrombosis, Diagnosis, Hospital, World Blood Donor Day, Caregiver, FDA, Hemostasis, Football, National Intrepid Center of Excellence, Disease, Children's Hospital of Philadelphia, Birth control, Pharmaceutical industry

PHILADELPHIA, June 7, 2023 /PRNewswire/ -- The Hemostasis and Thrombosis Center (HTC) at Children's Hospital of Philadelphia (CHOP) is proudly celebrating 50 years of providing comprehensive care to children and adolescents with hemophilia and other inherited bleeding or clotting disorders. The Center was founded in 1973 and was one of the first HTCs established in the country and is considered a Center of Excellence for the diagnosis, treatment and prevention of bleeding and clotting disorders, serving as a national resource for other institutions.

Key Points: 
  • PHILADELPHIA, June 7, 2023 /PRNewswire/ -- The Hemostasis and Thrombosis Center (HTC) at Children's Hospital of Philadelphia (CHOP) is proudly celebrating 50 years of providing comprehensive care to children and adolescents with hemophilia and other inherited bleeding or clotting disorders.
  • "What started at CHOP as caring for 48 patients a year with hemophilia has grown into providing care for over 1,000 children with all types of bleeding and clotting disorders at our Center," says Leslie Raffini, MD, Director of the Hemostasis and Thrombosis Center at Children's Hospital of Philadelphia.
  • Hemophilia is an X-linked inherited bleeding disorder that is caused by a clotting factor deficiency that can cause frequent, painful joint bleeds and disability.
  • During this time, donated blood was the only treatment available for hemophilia patients, which led to many of them becoming infected with HIV.